Pyrantel

Pyrantel
Clinical data
Trade names	Pin-X, Combantrin, others
Routes of; administration	by mouth
ATC code	P02CC01 (WHO) QP52AF02 (WHO);
Legal status
Legal status	US: OTC;
Pharmacokinetic data
Bioavailability	poorly absorbed
Identifiers
	IUPAC name 1-Methyl-2-[(E)-2-(2-thienyl)vinyl]-5,6-dihydro-4H-pyrimidine;
CAS Number	15686-83-6 ;
PubChem CID	708857;
DrugBank	DB11156;
ChemSpider	618121;
UNII	4QIH0N49E7;
KEGG	D08451;
ChEBI	CHEBI:8654;
ChEMBL	ChEMBL1626223;
CompTox Dashboard (EPA)	DTXSID5023538 ;
ECHA InfoCard	100.036.143
Chemical and physical data
Formula	C11H14N2S
Molar mass	206.31 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	178 to 179 °C (352 to 354 °F)
	SMILES CN1CCCN=C1/C=C/c2cccs2;
	InChI InChI=1S/C11H14N2S/c1-13-8-3-7-12-11(13)6-5-10-4-2-9-14-10/h2,4-6,9H,3,7-8H2,1H3/b6-5+; Key:YSAUAVHXTIETRK-AATRIKPKSA-N;

Pyrantel is a medication used to treat a number of parasitic worm infections.^[2] This includes ascariasis, hookworm infections, enterobiasis (pinworm infection), trichostrongyliasis, and trichinellosis.^[2] It is taken by mouth.^[2]

Side effects include nausea, headache, dizziness, trouble sleeping, and rash.^[2] A lower dose should be used in people with liver disease.^[2] While it does not appear to be harmful during pregnancy, it has not been studied for this use.^[3] It is unclear if it is safe for use during breastfeeding.^[2] It is in the antihelmintic family of medications.^[4] It works by paralyzing worms.^[4]

Pyrantel was initially described in 1965.^[5] It is on the World Health Organization's List of Essential Medicines.^[6] Pyrantel is available as a generic medication.^[4] It may also be used to treat worms in a number of other animals.^[5]

Pregnancy and breastfeeding

Pyrantel pamoate is considered a pregnancy category C drug for use during pregnancy for humans, but is in category A for canines and felines. Pyrantel is considered safe to use in nursing animals.^[7]

Mechanism of action

Pyrantel pamoate acts as a depolarizing neuromuscular blocking agent, thereby causing sudden contraction, followed by paralysis, of the helminths. This has the result of causing the worm to "lose its grip" on the intestinal wall and be passed out of the system by natural process. Since Pyrantel is poorly absorbed by the host's intestine, the host is unaffected by the small dosage of medication used. Spastic (tetanic) paralyzing agents, in particular pyrantel pamoate, may induce complete intestinal obstruction in a heavy worm load.^[8] This obstruction is usually in the form of a worm impaction and happens when a very small, but heavily parasitized animal is treated and tries to pass a large number of dislodged worms at once. Worms usually pass in normal stool or with diarrhea, straining, and occasional vomiting.

Names

There are a number of brands, including "Reese's Pinworm Medicine", "Pin-X", "Pin-Rid", "PYRANTRIN", "COMBANTRIN", "Anthel", "Helmintox", "Helmex", "Strongid" and Drontal Cat.

References

^ Hamilton R (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. p. 54. ISBN 9781284057560.
^ ^a ^b ^c ^d ^e ^f World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. pp. 89, 608. hdl:10665/44053. ISBN 9789241547659.
^ "Pyrantel Use During Pregnancy". Drugs.com. Archived from the original on 20 December 2016. Retrieved 8 December 2016.
^ ^a ^b ^c "Pyrantel Pamoate". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016.
^ ^a ^b Maddison JE, Page SW, Church DB (2008). Small Animal Clinical Pharmacology. Elsevier Health Sciences. p. 209. ISBN 978-0702028588. Archived from the original on 2016-12-20.
^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
^ Plumb DC (2005). Plumb's veterinary drug handbook. Stockholm, Wis: PharmaVet. ISBN 978-0-8138-0518-4.
^ Salman AB (April 1997). "Management of intestinal obstruction caused by ascariasis". Journal of Pediatric Surgery. 32 (4): 585–587. doi:10.1016/S0022-3468(97)90712-0. PMID 9126759.

External links

"Pyrantel". Drug Information Portal. U.S. National Library of Medicine.

[Ric2015-1] Hamilton R (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. p. 54. ISBN 9781284057560.

[WHO2008-2] ^ ^a ^b ^c ^d ^e ^f World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. pp. 89, 608. hdl:10665/44053. ISBN 9789241547659.

[3] "Pyrantel Use During Pregnancy". Drugs.com. Archived from the original on 20 December 2016. Retrieved 8 December 2016.

[AHFS2016-4] "Pyrantel Pamoate". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016.

[Mad2008-5] Maddison JE, Page SW, Church DB (2008). Small Animal Clinical Pharmacology. Elsevier Health Sciences. p. 209. ISBN 978-0702028588. Archived from the original on 2016-12-20.

[WHO21st-6] World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

[isbn0-8138-0518-X-7] Plumb DC (2005). Plumb's veterinary drug handbook. Stockholm, Wis: PharmaVet. ISBN 978-0-8138-0518-4.

[Salman1997-8] Salman AB (April 1997). "Management of intestinal obstruction caused by ascariasis". Journal of Pediatric Surgery. 32 (4): 585–587. doi:10.1016/S0022-3468(97)90712-0. PMID 9126759.

[1]